You are here: Industry Insights > Appointment

News List

Marksans Pharma appoints Dr Meena Rani Surana as Independent Woman Director expresspharma
September 07, 2020
She has about 27 years of experience in pharmaceutical regulatory affairs, quality assurance, formulation and pre-formulation.
Symbiosis Appoints COO contractpharma
August 27, 2020
Symbiosis Pharmaceutical Services has appointed John McCormick as chief operating officer and executive member of its Board of Directors.
Byondis Announces Appointment of Chief Financial Officer b3cnewswire
August 22, 2020
Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) is pleased to announce the appointment of Robbert Van Heekeren as chief financial officer.
Abzena Appoints Senior Director of Manufacturing contractpharma
August 19, 2020
Anu Bansal brings 20 years’ experience in the biopharmaceutical industry.
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors expresspharma
August 18, 2020
Bhattacharjee was previously President & CEO – Global Generic Medicines of Teva Pharmaceutical Industries.
Avomeen Appoints Formulation, Manufacturing Head contractpharma
July 17, 2020
Hashim Ahmed brings more than 25 years of experience from the biopharmaceutical and CDMO industries.
Rockwell Medical Announces Board of Directors Appointment americanpharmaceuticalreview
January 16, 2020
Rockwell Medical announced the appointment of Russell H. Ellison, MD, MSc, to its Board of Directors, effective January 9, 2020. Dr. Ellison has held leadership positions in both emerging biotechnology and large pharmaceutical companies for more than four
Vyome Announces Executive Management Appointment americanpharmaceuticalreview
January 13, 2020
Vyome Therapeutics announced the appointment of Craig Tooman as the Chief Operating Officer (COO) and Chief Financial Officer (CFO). Tooman brings more than 25 years of operating, financial, and M&A experience in the biotechnology and pharmaceutical indus
AzurRx BioPharma Announces Appointment of Daniel Schneiderman as Chief Financial Officer firstwordpharma
January 05, 2020
AzurRx BioPharma, Inc. (NASDAQ: AZRX) ("AzurRx" or the "Company"), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that Daniel Schneiderman has been appointed to serve as the
Accellix Announces Board of Directors Appointment americanpharmaceuticalreview
August 16, 2019
Accellix announces the appointment of a new Board Member, Charles (Chuck) Piazza.

Previous page 1 2 3 4 5 Next page